RxDoctor Payments Data

Jean-Baptiste le Pichon

Neurology with Special Qualifications in Child Neurology · Topeka, KSNPI 1649469362

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $8,500 of the $9,578 with a category attached, or 88.7%. Ionis Pharmaceuticals, Inc. accounts for 97.4% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $9,361, more than ten times the $38 reported in 2019.

$9,578in general payments, 2019–2025

Across 22 payments — averaging $435.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ionis Pharmaceuticals, Inc.$9K
  • Acadia Pharmaceuticals Inc$65
  • UCB, Inc.$59
  • Neurelis, Inc.$55
  • Sunovion Pharmaceuticals Inc.$35
  • Saol Therapeutics Inc.$25
  • plus $13 from 1 others
$805,729in research payments, 2019–2025

Across 15 payments — averaging $53,715 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ultragenyx Pharmaceutical Inc.$768K
  • Ionis Pharmaceuticals, Inc.$38K

What the payments were for

  • Consulting fees$8,50089%
  • Travel & lodging$6447%
  • Food & beverage$4325%
  • Education$20%

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few neurology with special qualifications in child neurology providers in Kansasto place this figure against a meaningful peer group, so we don't.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Acetazolamide12$118

Paid to pharmacies, not to this prescriber.

Other neurology with special qualifications in child neurology in Topeka

Where these figures come from

Is this you, or does something look wrong? →